Education
About Us
Working with TipRanks
Follow Us
Noile-Immune Biotech Inc. (JP:4893)
:4893
RESEARCH TOOLSreports
4893 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥120.00 - ¥353.00
Previous CloseN/A
Volume1.93M
Average Volume (3M)190.00K
Market Cap
¥7.23B
Enterprise Value¥23.48B
Total Cash (Recent Filing)¥4.67B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta1.32
Next Earnings
Nov 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.55
Shares Outstanding43,276,764
10 Day Avg. Volume280,500
30 Day Avg. Volume190,000
Financial Highlights & Ratios
PEG Ratio1.48
Price to Book (P/B)6.51
Price to Sales (P/S)0.00
P/FCF Ratio-261.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
4893 FAQ
What was Noile-Immune Biotech Inc.’s price range in the past 12 months?
Noile-Immune Biotech Inc. lowest stock price was ¥120.00 and its highest was ¥353.00 in the past 12 months.
What is Noile-Immune Biotech Inc.’s market cap?
Noile-Immune Biotech Inc.’s market cap is ¥7.23B.
When is Noile-Immune Biotech Inc.’s upcoming earnings report date?
Noile-Immune Biotech Inc.’s upcoming earnings report date is Nov 12, 2025 which is in 149 days.
How were Noile-Immune Biotech Inc.’s earnings last quarter?
Noile-Immune Biotech Inc. released its earnings results on May 12, 2025. The company reported -¥5.55 earnings per share for the quarter, missing the consensus estimate of N/A by -¥5.55.
Is Noile-Immune Biotech Inc. overvalued?
According to Wall Street analysts Noile-Immune Biotech Inc.’s price is currently Overvalued.
Does Noile-Immune Biotech Inc. pay dividends?
Noile-Immune Biotech Inc. does not currently pay dividends.
What is Noile-Immune Biotech Inc.’s EPS estimate?
Noile-Immune Biotech Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Noile-Immune Biotech Inc. have?
Noile-Immune Biotech Inc. has 43,276,764 shares outstanding.
What happened to Noile-Immune Biotech Inc.’s price movement after its last earnings report?
Noile-Immune Biotech Inc. reported an EPS of -¥5.55 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.704%.
Which hedge fund is a major shareholder of Noile-Immune Biotech Inc.?
Currently, no hedge funds are holding shares in JP:4893
Company Description
Noile-Immune Biotech Inc.
Noile-Immune Biotech Inc. researches and develops CAR-T cells for cancer immunotherapies. The company was incorporated in 2015 and is headquartered in Minato, Japan.
Technical Analysis
OncoTherapy Science
―
Cytori Cell Research Institute, Inc.
―
Oncolys BioPharma, Inc.
―
Delta-Fly Pharma, Inc.
―
Kringle Pharma, Inc.
―